## Background: Three types of membrane type-matrix metalloproteinases (mt-mmps) have been identified as activators of pro-mmp2 (gelatinase a/72-kilodalton type iv collagenase), which is believed to be crucial for tumor invasion and metastasis. mt1-mmp has been shown to be widely expressed in variou
Expression of membrane type 1 matrix metalloproteinase in medullary thyroid carcinoma: Prognostic implications
✍ Scribed by Beatriz Godoi Cavalheiro; Consuelo Rodrigues Junqueira; Lenine Garcia Brandão
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 324 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background.
Clinical and pathologic examinations cannot always provide a prognosis for patients with medullary thyroid carcinoma. Membrane type 1 matrix metalloproteinase (MT1‐MMP) can act directly on carcinogenesis and takes part in 1 of the processes of metalloproteinase 2 activation, an enzyme related to prognostic impairment of patients with such tumor.
Methods.
Thirty‐five patients who were submitted to surgery were followed up for an average of 74 months. Postoperative and final medical conditions were characterized for comparison with MT1‐MMP immunostainings, performed in surgical paraffin blocks. A value of p < .05 was considered statistically significant.
Results.
Proposed index (association of proportion and intensity of immunostaining) and proportion of immunostained cells in primary specimens were correlated with cure or persistence after initial operations (p = .0216 and p = .0098, respectively).
Conclusion.
MT1‐MMP immunostaining in primary tumor specimens is a new and complementary prognostic predictor in patients with medullary thyroid carcinomas. © 2009 Wiley Periodicals, Inc. Head Neck, 2010
📜 SIMILAR VOLUMES
## Background: The 5-year survival rate of patients with submucosal (sm) esophageal carcinoma continues to be much worse than that with intramucosal (m) lesions. the reasons are unclear, but matrix metalloproteinases (mmps) and membrane type matrix metalloproteinases (mt-mmps) are known to be invol
Recently a novel membrane-type matrix metalloproteinase-1 (MT-MMP-1) was discovered to be a specific activator of progelatinase A, and was correlated with tumor invasion. To the authors' knowledge, no information regarding the expression of MT-MMP-1 has been reported in childhood malignancies. In th